CYTOKINETICS, INCORPORATED Adjustments to Additional Paid in Capital, Warrant Issued
CYTOKINETICS, INCORPORATED (CYTK) reported Adjustments to Additional Paid in Capital, Warrant Issued of $184.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2023-03-01.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2023-03-01
- CYTOKINETICS, INCORPORATED adjustments to additional paid in capital, warrant issued for the quarter ending 2020-03-31 was $184.00K.
- CYTOKINETICS, INCORPORATED adjustments to additional paid in capital, warrant issued for the quarter ending 2019-06-30 was $185.00K.
- CYTOKINETICS, INCORPORATED adjustments to additional paid in capital, warrant issued for the quarter ending 2018-12-31 was $0.00.
- CYTOKINETICS, INCORPORATED adjustments to additional paid in capital, warrant issued for the quarter ending 2018-09-30 was $182.00K.
- CYTOKINETICS, INCORPORATED adjustments to additional paid in capital, warrant issued for fiscal 2020 was $184.00K, a 0.54% decline from fiscal 2019.
- CYTOKINETICS, INCORPORATED adjustments to additional paid in capital, warrant issued for fiscal 2019 was $185.00K, a 1.65% increase from fiscal 2018.
- CYTOKINETICS, INCORPORATED adjustments to additional paid in capital, warrant issued for fiscal 2018 was $182.00K.
- CYTOKINETICS, INCORPORATED adjustments to additional paid in capital, warrant issued for fiscal 2016 was $288.00K, a 2.13% increase from fiscal 2015.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2020-12-31 | $184.00K 10-K · filed 2023-03-01 | |||
| 2020-03-31 | $184.00K 10-Q · filed 2021-11-05 | |||
| 2019-12-31 | $185.00K 10-K · filed 2022-02-25 | |||
| 2019-06-30 | $185.00K 10-Q · filed 2020-11-06 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $182.00K derived: sum of 2 quarters · filed 2021-02-26 | $182.00K 10-K · filed 2021-02-26 | |
| 2018-09-30 | $182.00K 10-Q · filed 2019-11-01 | $182.00K 10-Q · filed 2018-11-09 | ||
| 2016-12-31 | $288.00K 10-K · filed 2018-03-05 | |||
| 2015-12-31 | $282.00K 10-K · filed 2018-03-05 | |||
| 2012-12-31 | $13.76M 10-K · filed 2015-03-06 | |||
| 2011-12-31 | $4.43M 10-K · filed 2014-03-07 | |||
| 1999-12-31 | $41.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |